Bezlotoxumab (BEZLO)

bezlotoxumab · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bezlotoxumab (BEZLO), covering 2022-05-26 to 2022-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection [Phase 4]

See pricing